Dipropyltryptamine

EN Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.

Dipropyltryptamine (DPT), also known as N,N-dipropyltryptamine or as "The Light", is a psychedelic drug of the tryptamine family related to dimethyltryptamine (DMT) and diethyltryptamine (DET). It is taken orally or by other routes such as smoking, insufflation, or injection. It has a relatively short duration of 2 to 4 hours orally or insufflated and 20 minutes to 2 hours smoked. The drug acts as a serotonin receptor modulator, including as a serotonin 5-HT2A receptor agonist. It is a close structural homologue of DMT and DET and is a skeletal isomer of diisopropyltryptamine (DiPT). Derivatives of DPT include 4-HO-DPT and 5-MeO-DPT, among others. DPT was first described in the literature by 1954. Its hallucinogenic effects were first described in 1966. The drug was encountered as a novel designer drug by 1968 and was reported as a possible treatment for alcoholism in 1973. DPT has never been made an explicitly controlled substance in the United States. It is the sacrament of the Temple of the True Inner Light, a New York City-based psychedelic church, which considers DPT and other psychedelics to be God.